2020 Scientific Sessions

Michelle Lewis

Michelle Lewis
Caladrius Biosciences
Rye Brook, NY
USA

Papers:

Autologous CD34 Cell Therapy for Treatment of Coronary Microvascular Dysfunction in Patients With Angina and Non-Obstructive Coronary Arteries